Navigation Links
Surveyed Specialists Foresee Greater Use of Parenteral Outpatient Therapy for the Treatment of Osteomyelitis
Date:4/21/2009

A Drug's Safety Profile is the Leading Attribute in Antibiotic Selection, According to a New Report from AMR and Decision Resources

MALVERN, Pa. and WALTHAM, Mass., April 21 /PRNewswire/ -- Arlington Medical Resources (AMR) and Decision Resources find that in addition to surveyed infectious disease specialists' prediction that empiric coverage of methicillin-resistant Staphylococcus aureus (MRSA) will increase, they foresee greater use of parenteral outpatient therapy (intravenous or intramuscular injection) for the treatment of osteomyelitis. Osteomyelitis is an infection of bone or bone marrow caused by bacterial infections.

"Osteomyelitis often requires an extended duration of antibiotic therapy after hospital discharge and many patients are prescribed an injectable agent," stated Lisa Arias, analyst at Decision Resources. "Nearly one-third of surveyed physicians expect increased use of parenteral antibiotic therapy in the next five years."

The new report entitled Hospital Anti-Infectives Insight Series: Osteomyelitis also finds that although surveyed infectious disease specialists look for a range of attributes when prescribing an antibiotic for osteomyelitis, the leading attribute, by far, is the drug's safety profile when administered over a long period of time -- 77 percent of surveyed physicians cited this attribute as extremely important. Physicians also look for an antibiotic that can be dosed, administered and monitored easily in the outpatient setting. Other important factors are the drug's ability to penetrate bone and activity against MRSA.

About Hospital Anti-Infectives Insight Series

AMR and Decision Resources' Hospital Anti-Infectives Insight Series analyzes hospital antibiotic prescribing patterns using AMR's comprehensive and hig
'/>"/>

SOURCE Decision Resources; Arlington Medical Resources
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine news :

1. World Vision Index of Concern: Half of Americans Surveyed Said They Would Be Willing to Pay More Taxes to Combat AIDS
2. Eighty-Nine Percent of Surveyed Rheumatologists Say They Will Prescribe Roche/Chugais Actemra for Rheumatoid Arthritis
3. Surveyed Neurologists in Both the U.S. and Europe Would Welcome an Antiepileptic Drug That is Administered Once-Daily
4. Half of Full-Time Employees Surveyed Dont Understand Health Insurance Coverage for Cancer-Related Medical Expenses
5. Surveyed Gastroenterologists Indicate That Humira Has Advantages Over Remicade in Maintaining Clinical Remission of Crohns Disease
6. Less Than Two-Thirds of Surveyed Pharmacy Directors Expect to Reimburse Both Onglyza and Alogliptin Once They are Available for the Treatment of Type 2 Diabetes
7. As a Result of the Jupiter Trial, 65 Percent of Surveyed MCO Pharmacy Directors Will Reimburse Crestor for Patients with Elevated hsCRP
8. Surveyed Oncologists Indicate that Avastin has Advantages over Temodar/Temodal in Increasing Overall Survival of High-Grade Glioma
9. Surveyed Experts Indicate That Xarelto Has Advantages Over Lovenox in the Treatment of Venous Thromboembolism in Medically Ill Patients
10. Surveyed Experts Indicate that Biogen Idecs Adentri Has Advantages Over Nitroglycerin in the Treatment of Acute Heart Failure
11. As a Result of the FDA Investigation Into TNF-Alpha Inhibitors, 30 Percent of Surveyed Rheumatologists Have Altered Their Prescription Patterns for Juvenile Idiopathic Arthritis
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/3/2015)... , ... August 03, 2015 , ... Sutter Health’s California ... operating officer (COO) at CPMC. Hamila will start in her role effective immediately and ... , Kownacki has worked at CPMC and Sutter Health for about 15 years, including ...
(Date:8/3/2015)... ... August 03, 2015 , ... The Workgroup for Electronic ... health IT to create efficiencies in healthcare information exchange, announced the release of its ... Health and Human Services (HHS) Secretary, WEDI shared survey results and ...
(Date:8/3/2015)... ... 03, 2015 , ... Kantor & Kantor, LLP announced today ... client Rebecca Hamsher, deciding that in accordance with ERISA ( Employee Retirement Income ... treatment for bulimia, depression and other mental health problems. , According to the ...
(Date:8/3/2015)... (PRWEB) , ... August 03, 2015 , ... ... Health notes that while an overwhelming number of Hispanics believe people can ... The overwhelming 70 percent of participants queried said making diet changes was important. ...
(Date:8/3/2015)... ... August 03, 2015 , ... ... its industry-defining contract lifecycle management solution, as well as announced the date of ... the speed and ease of contract management tasks as well as enhancements to ...
Breaking Medicine News(10 mins):Health News:Hamila Kownacki, RN Appointed as New Chief Operating Officer at CPMC 2Health News:WEDI ICD-10 Survey Results: Industry Nearing Readiness but Physician Practices Lagging Behind 2Health News:WEDI ICD-10 Survey Results: Industry Nearing Readiness but Physician Practices Lagging Behind 3Health News:WEDI ICD-10 Survey Results: Industry Nearing Readiness but Physician Practices Lagging Behind 4Health News:Kantor & Kantor Announces North Cypress Medical Center Must Reimburse Benefits for Mental Health Treatment 2Health News:Kantor & Kantor Announces North Cypress Medical Center Must Reimburse Benefits for Mental Health Treatment 3Health News:Hispanics More Likely to Struggle with Misinformation About Diabetes 2Health News:Hispanics More Likely to Struggle with Misinformation About Diabetes 3Health News:Hispanics More Likely to Struggle with Misinformation About Diabetes 4Health News:Novatus Unveils Milestone Software Release 2
... Feb. 6 MaxCyte, Inc., a,clinical-stage therapeutics company ... Douglas Doerfler, President & CEO, will be,presenting at ... York,Waldorf=Astoria, on Monday, February 11, 2008 at 11:45AM., ... overview and discuss the,company,s preclinical and clinical product ...
... of nevirapine greatly reduced infant infections in Africa, ... News) -- The antiretroviral drug nevirapine greatly reduces ... virus to their babies during breast-feeding, according to ... Nevirapine is already in widespread use in developing ...
... Introduces World,s First Collaborative Platform to Integrate, ... WAYLAND, Mass., Feb. 6 Tourtellotte ... for the bio-pharmaceutical industry, is,pleased to announce ... document,management and collaboration platform for complex document ...
... Inc. (Amex:,UPI), a medical device company that develops, ... of voiding dysfunction,announced today that it will be ... on Wednesday, February 20, 2008 at the Ritz ... and Medi Jiwani,Uroplasty,s Vice President and CFO, will ...
... PHILADELPHIA, Feb. 6 The much,anticipated launch ... eToims(R),Soft Tissue Comfort Center, LLC, a University ... Intramuscular,Stimulation (eToims(R) Twitch Relief Method). The site ... including back pain (the second most,common neurological ...
... well as standard, invasive method , , TUESDAY, Feb. 5 (HealthDay ... cancer has spread may be better than traditional, invasive procedures. ... of the Journal of the American Medical Association , ... era for people with lung cancer or suspected lung cancer. ...
Cached Medicine News:Health News:Drug Helps Prevent Breast-Feeding Moms From Passing on HIV 2Health News:Tourtellotte Solutions' Fusion DMC(TM) Unifies the World of Bio-Pharma Documents 2Health News:StopMusclePain.com Launched as Only Website Dedicated to Reversing Back Pain 2Health News:Less Invasive Way to Stage Lung Cancer Shows Promise 2Health News:Less Invasive Way to Stage Lung Cancer Shows Promise 3
(Date:8/3/2015)... , Aug. 3, 2015  Depomed, Inc. (NASDAQ: ... Horizon Pharma plc,s (NASDAQ: HZNP ) ("Horizon") announcement ... Directors ("Depomed Board") set a record date to determine ... The Depomed Board will review the request ... received today and contains the information required under Depomed,s ...
(Date:8/3/2015)... According to a new ... Market Study on Physiotherapy Equipment - ... 2022", the global physiotherapy equipment market is estimated to be ... and is expected to grow at a CAGR ... for US$23.7 Bn by 2022. View Full ...
(Date:8/3/2015)... , August 3, 2015 ... biotech companies, military surgical research and top-tier ... with regards to severe wound treatments for ... for regenerative medicine and tissue-engineered skin substitute ... and advancements in focus are Amarantus Bioscience ...
Breaking Medicine Technology:Depomed Comments on Horizon Pharma Announcement 2Depomed Comments on Horizon Pharma Announcement 3Depomed Comments on Horizon Pharma Announcement 4Depomed Comments on Horizon Pharma Announcement 5Depomed Comments on Horizon Pharma Announcement 6Global Physiotherapy Equipment Market Will Reach US$ 23.7 Billion by 2022: Persistence Market Research 2Global Physiotherapy Equipment Market Will Reach US$ 23.7 Billion by 2022: Persistence Market Research 3Global Physiotherapy Equipment Market Will Reach US$ 23.7 Billion by 2022: Persistence Market Research 4Biotech Advancements Coupled with Collaborative Partnerships Focus on Developing Orphan Drug Products & Treatments for Critical-Care Patients With Severe Wound Conditions 2Biotech Advancements Coupled with Collaborative Partnerships Focus on Developing Orphan Drug Products & Treatments for Critical-Care Patients With Severe Wound Conditions 3Biotech Advancements Coupled with Collaborative Partnerships Focus on Developing Orphan Drug Products & Treatments for Critical-Care Patients With Severe Wound Conditions 4Biotech Advancements Coupled with Collaborative Partnerships Focus on Developing Orphan Drug Products & Treatments for Critical-Care Patients With Severe Wound Conditions 5Biotech Advancements Coupled with Collaborative Partnerships Focus on Developing Orphan Drug Products & Treatments for Critical-Care Patients With Severe Wound Conditions 6
... is a lateral-flow immuno-chromatographic assay intended for ... specific to Helicobacter pylori in human serum, ... convenient, non-invasive, and easy to perform test ... of H.pylori infection in patients with clinical ...
... HP is a visually read, qualitative immunochromatographic ... H. pylori, a bacterium that grows in ... ulcer disease and some gastric cancers. FlexSure ... blood or serum samples, provides the physician ...
... Infectious Mononucleosis test is designed to ... serum, plasma or whole blood. The ... extract of bovine erythrocytes which give ... similar extracts prepared from sheep and ...
... The QuickVue Influenza A+B test ... of influenza type A and type ... nasal wash and/or nasal aspirate specimens. ... aid in the rapid differential diagnosis ...
Medicine Products: